Aimmune Therapeutics
Biotechnology, 8000 Marina BLVD Ste 300, Brisbane, California, 94005, United States, 501-1000 Employees
Phone Number: +18*********
Who is AIMMUNE THERAPEUTICS
Aimmune Therapeutics, Inc., a Nestle Health Science Company, is a biopharmaceutical company developing and commercializing treatments for potentially life-threatening food allergies. With...
Read More
-
Headquarters: 8000 Marina BLVD Ste 300, Brisbane, California, 94005, United States
-
Date Founded: 2011
-
Employees: 501-1000
-
Revenue: $1 Million to $5 Million
-
Active Tech Stack: See technologies
Industry: Biotechnology
SIC Code: 2834
|
NAICS Code: 325412 |
Show More
Does something look wrong? Fix it. | View contact records from AIMMUNE THERAPEUTICS
Aimmune Therapeutics Org Chart and Mapping
Email
Phone
Cindi Hein
Regional Director, Hospital Sales West at Aimmune Therapeutics a Nestle Health Science Company
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding Aimmune Therapeutics
Answer: Aimmune Therapeutics's headquarters are located at 8000 Marina BLVD Ste 300, Brisbane, California, 94005, United States
Answer: Aimmune Therapeutics's phone number is +18*********
Answer: Aimmune Therapeutics's official website is https://aimmune.com
Answer: Aimmune Therapeutics's revenue is $1 Million to $5 Million
Answer: Aimmune Therapeutics's SIC: 2834
Answer: Aimmune Therapeutics's NAICS: 325412
Answer: Aimmune Therapeutics has 501-1000 employees
Answer: Aimmune Therapeutics is in Biotechnology
Answer: Aimmune Therapeutics contact info: Phone number: +18********* Website: https://aimmune.com
Answer: Aimmune Therapeutics, Inc., a Nestle Health Science Company, is a biopharmaceutical company developing and commercializing treatments for potentially life-threatening food allergies. With a mission to improve the lives of people with food allergies, Aimmune is developing and commercializing oral treatments for potentially life-threatening food allergies. The Companys Characterized Oral Desensitization ImmunoTherapy (CODITTM) approach is intended to provide meaningful levels of protection against allergic reactions resulting from accidental exposure to food allergens by desensitizing patients with defined, precise amounts of key allergens. Aimmune has one FDA-approved medicine for peanut allergy and other investigational therapies in development to treat other food allergies. Aimmune is located in Brisbane, California - the heart of San Franciscos biotechnology hub - with additional offices in Durham, North Carolina; the Paddington area of London, England; Dublin, Ireland; and Munich, Germany. **The information on Aimmunes LinkedIn channel including any product information - is intended for U.S. residents only and is governed by applicable U.S. laws and regulations. Any information on the products contained herein is not intended to provide medical advice nor should be used as a substitute for the advice provided by your physician or other healthcare provider.
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Sign in to CIENCE GO Data to uncover contact details
Free credits every month